by AnTolRx | Oct 2, 2019 | Updates
We will be presenting data on AnTolRx’s antigen-specific nanoformulation platform. Join us in Woods Hole, MA, on October 12-13th, 2019. http://www.newenglandimmunology.org by AnTolRx | Mar 5, 2019 | Press Release
CAMBRIDGE, Mass., March 5,2019 – AnTolRx, Inc., a private biotechnology company and a leader in immune tolerance, today announced that Pfizer Inc. (NYSE: PFE) has exercised the option granted under a June 2016 agreement to license an immune... by AnTolRx | Mar 1, 2019 | Updates
Dr. Sara Tezza will be presenting data on AnTolRx’s antigen-specific nanoformulation platform. Join us in Boston March 26-28, 2019. http://as-immunetolerance.com by AnTolRx | Feb 5, 2019 | Publication
Rothhammer, V. and Quintana, F. Nat Rev Immunol. (2019) by AnTolRx | Jan 1, 2019 | Updates
We are excited to attend this year’s 37th annual JP Morgan Healthcare conference in San Francisco, CA this Monday January 7th through the 10th.